Also categorized in PubMed:
Immunological Resolution of Human Chronic Graft-versus-Host Disease.
x hide permanently

Immune Escape Mechanisms and Future Prospects for Immunotherapy in Neuroblastoma.

ncbi.nlm.nih.gov

Immune Escape Mechanisms and Future Prospects for Immunotherapy in Neuroblastoma.

Biomed Res Int. 2018;2018:1812535

Authors: Vanichapol T, Chutipongtanate S, Anurathapan U, Hongeng S

Abstract Neuroblastoma (NB) is the most common extracranial solid tumor in childhood with 5-year survival rate of 40% in high-risk patients despite intensive therapies.

Mentions: Immunotherapy